Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
110.14B
Market cap110.14B
Price-Earnings ratio
38.21
Price-Earnings ratio38.21
Dividend yield
Dividend yield
Average volume
25.98M
Average volume25.98M
High today
$75.42
High today$75.42
Low today
$73.92
Low today$73.92
Open price
$74.84
Open price$74.84
Volume
21.08M
Volume21.08M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$73.92
52 Week low$73.92

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $74.50. The company's market cap stands at 110.14B, with a P/E ratio of 38.21.

On 2026-02-10, Boston Scientific(BSX) stock moved within a range of $73.92 to $75.42. With shares now at $74.50, the stock is trading +0.8% above its intraday low and -1.2% below the session's peak.

Trading activity shows a volume of 21.08M, compared to an average daily volume of 25.98M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $73.92.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $73.92.

BSX News

Simply Wall St 1d
Boston Scientific Valuation Check After Earnings Strength And Softer Electrophysiology And Watchman Trends

Advertisement Earnings catalyst and shifting sentiment Boston Scientific (BSX) is back in focus after its latest earnings report, where solid year over year g...

Boston Scientific Valuation Check After Earnings Strength And Softer Electrophysiology And Watchman Trends
TipRanks 1d
Boston Scientific: Multi-Year Double-Digit Growth Outlook Makes Share Pullback a Buy Opportunity

Citi analyst Joanne Wuensch reiterated a Buy rating on Boston Scientific yesterday and set a price target of $102.00. Joanne Wuensch has given his Buy rating d...

TipRanks 2d
Boston Scientific: Durable Growth, Expanding EP Opportunity, and Upside-Skewed Valuation Justify Buy Rating

J.P. Morgan analyst Robbie Marcus maintained a Buy rating on Boston Scientific today and set a price target of $100.00. Robbie Marcus has given his Buy rating...

Analyst ratings

97%

of 36 ratings
Buy
97.2%
Hold
2.8%
Sell
0%

More BSX News

Simply Wall St 3d
Penumbra Sale To Boston Scientific Recasts Growth Story For Investors

Penumbra (NYSE:PEN) is set to be acquired by Boston Scientific in a US$14.5b deal, following the release of strong quarterly results. The transaction, announce...

Penumbra Sale To Boston Scientific Recasts Growth Story For Investors
TipRanks 4d
Boston Scientific price target lowered to $112 from $130 at Bernstein

Bernstein analyst Lee Hambright lowered the firm’s price target on Boston Scientific (BSX) to $112 from $130 and keeps an Outperform rating on the shares. The f...

Simply Wall St 4d
Does Boston Scientific Signal a Strategic Shift as EP and WATCHMAN Growth Levels Off?

Boston Scientific reported fourth-quarter and full-year 2025 results on February 4, 2026, delivering higher sales and net income, while also issuing 2026 guidan...

Does Boston Scientific Signal a Strategic Shift as EP and WATCHMAN Growth Levels Off?
TipRanks 5d
Boston Scientific announces planned board director departure

Boston Scientific ( (BSX) ) has shared an announcement. On February 2, 2026, Boston Scientific announced that long-serving director Yoshiaki Fujimori, who join...

Benzinga 5d
Boston Scientific Analyst Slashes Price Target On Disappointing 2026 Outlook

The Boston Scientific Analyst: Analyst Mike Matson maintained a Buy rating, but slashed the price target from $121 to $97. The Boston Scientific Thesis: The co...

Boston Scientific Analyst Slashes Price Target On Disappointing 2026 Outlook
Benzinga 5d
Boston Scientific Analysts Cut Their Forecasts Following Q4 Results

Boston Scientific Corporation (NYSE:BSX) reported upbeat earnings for the fourth quarter on Wednesday. The company posted fourth-quarter 2025 revenues of $5.29...

Boston Scientific Analysts Cut Their Forecasts Following Q4 Results
TipRanks 6d
Spotify, Boston Scientific removed from ‘US 1 List’ at BofA

BofA analysts are removing Boston Scientific (BSX) and Spotify (SPOT) from the firm’s “US 1 List,” which represents a collection of the best investment ideas dr...

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.